View Item 

Show simple item record

Enkephalin-dopamine interactions in behavioral arousal
dc.contributor.authorKatz, Richard J.en_US
dc.contributor.authorCarroll, Bernard J.en_US
dc.date.accessioned2006-04-07T17:40:10Z
dc.date.available2006-04-07T17:40:10Z
dc.date.issued1979en_US
dc.identifier.citationKatz, R. J., Carroll, Bernard J. (1979)."Enkephalin-dopamine interactions in behavioral arousal." Progress in Neuro-Psychopharmacology 3(4): 395-398. <http://hdl.handle.net/2027.42/23732>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B73FH-4C7WMB8-1J/2/e5719ae0742229f5dbc7ba8caa1873aden_US
dc.identifier.urihttps://hdl.handle.net/2027.42/23732
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=45569&dopt=citationen_US
dc.description.abstract1. 1. Central injection of a long lasting enkephalin analog (D-Ala2-leuo-enkephalin-amide) produced a syndrome of stereotyped motor activity.2. 2. This activation syndrome was significantly reduced by two dopamine (DA) blockers (pimozide, fluspirilene) and by an agonist of inhibition-mediating DA receptors [(3,4-dihydroxyphenylamino)-2-imidazoline].3. 3. Intact DA functioning is necessary for the occurrence of this enkephalin-mediated behavioral syndrome.en_US
dc.format.extent266340 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleEnkephalin-dopamine interactions in behavioral arousalen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychiatry, Mental Health Research Institute, The University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Psychiatry, Mental Health Research Institute, The University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.identifier.pmid45569en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/23732/1/0000704.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0364-7722(79)90052-3en_US
dc.identifier.sourceProgress in Neuro-Psychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0000704.pdf
Size:
260.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.